je.st
news
J&J in deal to develop microbiome drug for bowel diseases
2015-01-13 15:23:06| Food - Topix.net
Johnson & Johnson on Tuesday announced a licensing deal with Vedanta Biosciences to develop the privately held company's lead microbiome-based drug candidate for inflammatory bowel disorders, such as Crohn's disease and ulcerative colitis. J&J said Vedanta will receive an undisclosed upfront payment and would be eligible to receive up to $241 million for achieving development and commercial milestones.
Tags: deal
develop
drug
diseases
Category:Food and Related Products
Latest from this category |
All news |
||
|
|||